Potent anti-leukemia activities of humanized CD19-targeted Chimeric antigen receptor T (CAR-T) cells in patients with relapsed/refractory acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

Potent anti-leukemia activities of humanized CD19-targeted Chimeric antigen receptor T (CAR-T) cells in patients with relapsed/refractory acute lymphoblastic leukemia

Published:2018-04-28 Issue:7 Volume:93 Page:851-858
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Cao Jiang¹,Wang Gang²,Cheng Hai¹,Wei Chen¹,Qi Kunming¹,Sang Wei¹,Zhenyu Li¹,Shi Ming²,Li Huizhong²,Qiao Jianlin³,Pan Bin³,Zhao Jing¹,Wu Qingyun³,Zeng Lingyu³,Niu Mingshan³^ORCID,Jing Guangjun⁴,Zheng Junnian²⁵⁶,Xu Kailin¹³^ORCID

Affiliation:

1. Department of Hematology; The Affiliated Hospital of Xuzhou Medical University; Xuzhou 221002 China

2. Cancer Institute, Xuzhou Medical University; Xuzhou 221002 China

3. Jiangsu Bone Marrow Stem Cell Institute; Xuzhou 221002 China

4. iCARTAB biomedical co. LTD; Suzhou 215000 China

5. Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Cancer Institute, Xuzhou Medical University; Xuzhou 221002 China

6. Center of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University; Xuzhou 221002 China

Funder

National Natural Science Foundation of China

Jiangsu Province Social Development Key Projects

China Postdoctoral Science Foundation funded project

Jiangsu Provincial Key Medical Discipline (Laboratory)

Xuzhou Science and Technology Plan Projects

Publisher

Wiley

Subject

Hematology

Reference33 articles.

1. Current status and perspectives of chimeric antigen receptor modified T cells for cancer treatment;Wang;Protein Cell.,2017

2. Chimeric antigen receptor T-cell therapies for lymphoma;Brudno;Nat Rev Clin Oncol.,2017

3. Novel immunotherapies for adult patients with B-lineage acute lymphoblastic leukemia;Wei;J Hematol Oncol.,2017

4. Interleukin-armed chimeric antigen receptor-modified T cells for cancer immunotherapy;Huang;Gene Ther.,2017

5. The multi-purpose tool of tumor immunotherapy: gene-engineered T cells;Mo;J Cancer.,2017

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytokine Release Syndrome Following CD19 Directed Chimeric Antigen Receptor T-Cell Therapy;Manual of Hematopoietic Cell Transplantation and Cellular Therapies;2024

2. Chimeric Antigen Receptor T-Cell Therapy in Acute Lymphoblastic Leukemia;Manual of Hematopoietic Cell Transplantation and Cellular Therapies;2024

3. Expanding CAR-T cell immunotherapy horizons through microfluidics;Lab on a Chip;2024

4. IL-21-armored B7H3 CAR-iNKT cells exert potent antitumor effects;iScience;2024-01

5. Comparison of blinatumomab and CAR T-cell therapy in relapsed/refractory acute lymphoblastic leukemia: a systematic review and meta-analysis;Expert Review of Hematology;2023-12-22